The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Antioxidants, inflammation and cardiovascular disease
Open accessAbstract
Multiple factors are involved in the etiology of cardiovascular disease (CVD). Pathological changes occur in a variety of cell types long before symptoms become apparent and diagnosis is made. Dysregulation of physiological functions are associated with the activation of immune cells, leading to local and finally systemic inflammation that is characterized by production of high levels of reactive oxygen species (ROS). Patients suffering from inflammatory diseases often present with diminished levels of antioxidants either due to insufficient dietary intake or, and even more likely, due to increased demand in situations of overwhelming ROS production by activated immune effector cells like macrophages. Antioxidants are suggested to beneficially interfere with diseases-related oxidative stress, however the interplay of endogenous and exogenous antioxidants with the overall redox system is complex. Moreover, molecular mechanisms underlying oxidative stress in CVD are not fully elucidated. Metabolic dybalances are suggested to play a major role in disease onset and progression. Several central signaling pathways involved in the regulation of immunological, metabolic and endothelial function are regulated in a redox-sensitive manner. During cellular immune response, interferon γ-dependent pathways are activated such as tryptophan breakdown by the enzyme indoleamine 2,3-dioxygenase (IDO) in monocyte-derived macrophages, fibroblasts, endothelial and epithelial cells. Neopterin, a marker of oxidative stress and immune activation is produced by GTP-cyclohydrolase I in macrophages and dendritic cells. Nitric oxide synthase (NOS) is induced in several cell types to generate nitric oxide (NO). NO, despite its low reactivity, is a potent antioxidant involved in the regulation of the vasomotor tone and of immunomodulatory signaling pathways. NO inhibits the expression and function of IDO. Function of NOS requires the cofactor tetrahydrobiopterin (BH4), which is produced in humans primarily by fibroblasts and endothelial cells. Highly toxic peroxynitrite (ONOO(-)) is formed solely in the presence of superoxide anion (O2 (-)). Neopterin and kynurenine to tryptophan ratio (Kyn/Trp), as an estimate of IDO enzyme activity, are robust markers of immune activation in vitro and in vivo. Both these diagnostic parameters are able to predict cardiovascular and overall mortality in patients at risk. Likewise, a significant association exists between increase of neopterin concentrations and Kyn/Trp ratio values and the lowering of plasma levels of vitamin-C, -E and -B. Vitamin-B deficiency is usually accompanied by increased plasma homoycsteine. Additional determination of NO metabolites, BH4 and plasma antioxidants in patients with CVD and related clinical settings can be helpful to improve the understanding of redox-regulation in health and disease and might provide a rationale for potential antioxidant therapies in CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282004 · Cited by 2,347
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Cardiovascular Diseases (CVDs)
(2022) · Biochips and Medical Imaging · doi:10.1002/9781118910573.ch5 · Cited by 1,281
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7674 · Cited by 1,238
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Macrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., & Wachter, H. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.1.310 · Cited by 1,084
Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Nutrient sensing and inflammation in metabolic diseases
Hotamisligil, G. S., & Erbay, E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2449 · Cited by 1,040
Immunity, atherosclerosis and cardiovascular disease
Frostegård, J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-117 · Cited by 1,040
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037
Molecular Mechanisms RegulatinG Th1 Immune Responses
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140942 · Cited by 1,019
The chemical biology of nitric oxide: Implications in cellular signaling
Thomas, D. D., Ridnour, L. A., Isenberg, J. S., Flores-Santana, W., Switzer, C. H., Donzelli, S., Hussain, P., Vecoli, C., Paolocci, N., Ambs, S., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.020 · Cited by 975
Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093660.86242.bb · Cited by 941
Nitric oxide and redox mechanisms in the immune response
Wink, D. A., Hines, H. B., Cheng, R. Y. S., Switzer, C. H., Flores-Santana, W., Vitek, M. P., Ridnour, L. A., & Colton, C. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1010550 · Cited by 765
The oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Neopterin as a Marker for Immune System Activation
Murr, C., Widner, B., Wirleitner, B., & Fuchs, D. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605082 · Cited by 738
Laursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093661.90582.c4 · Cited by 721
Homocysteine and vascular disease
McCully, K. S. (1996) · Nature Medicine · doi:10.1038/nm0496-386 · Cited by 702
Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F., & Collen, D. (1998) · Circulation · doi:10.1161/01.cir.98.15.1487 · Cited by 673
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Libby, P., Lichtman, A. H., & Hansson, G. K. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.009 · Cited by 671
Biochemical Aspects of Phagocytosis
IYER, G. Y. N., ISLAM, M. F., & QUASTEL, J. H. (1961) · Nature · doi:10.1038/192535a0 · Cited by 663
Distribution of macrophage polarization markers in human atherosclerosis
Stöger, J. L., Gijbels, M. J. J., van der Velden, S., Manca, M., van der Loos, C. M., Biessen, E. A. L., Daemen, M. J. A. P., Lutgens, E., & de Winther, M. P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.013 · Cited by 621
Fleetwood, A. J., Lawrence, T., Hamilton, J. A., & Cook, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5245 · Cited by 607
Scavenger receptors in innate immunity
Peiser, L., Mukhopadhyay, S., & Gordon, S. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00307-7 · Cited by 534
Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease
Holvoet, P., Mertens, A., Verhamme, P., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E., & Van de Werf, F. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.5.844 · Cited by 530
Preadipocyte Conversion to Macrophage
Charrière, G., Cousin, B., Arnaud, E., André, M., Bacou, F., Pénicaud, L., & Casteilla, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210811200 · Cited by 520
Developmental origins of metabolic disease: Life course and intergenerational perspectives
Godfrey, K. M., Gluckman, P. D., & Hanson, M. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.008 · Cited by 485
Inflammation, Atherosclerosis, and Coronary Artery Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejm200507283530425 · Cited by 476
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh, I. M., Shishehbor, M. H., & Ansell, B. J. (2007) · JAMA · doi:10.1001/jama.298.7.786 · Cited by 468
Bostom, A. G., Rosenberg, I. H., Silbershatz, H., Jacques, P. F., Selhub, J., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00006 · Cited by 438
Meisinger, C., Baumert, J., Khuseyinova, N., Loewel, H., & Koenig, W. (2005) · Circulation · doi:10.1161/circulationaha.104.529297 · Cited by 434
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Dietary antioxidants in preventing atherogenesis
Kaliora, A. C., Dedoussis, G. V. Z., & Schmidt, H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.001 · Cited by 417
Endothelium-Dependent Effects of Statins
Wolfrum, S., Jensen, K. S., & Liao, J. K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000063385.12476.a7 · Cited by 417
Simultaneous Measurement of Serum Tryptophan and Kynurenine by HPLC,
Widner, B., Werner, E. R., Schennach, H., Wachter, H., & Fuchs, D. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2424 · Cited by 411
Feelisch, M., Rassaf, T., Mnaimneh, S., Singh, N., Bryan, N. S., Jourd'Heuil, D., & Kelm, M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0363com · Cited by 401
Small, D. M. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.2.103 · Cited by 389
Reactive oxygen species and the mitochondrial signaling pathway of cell death.
Bras, M. L., Clément, M.-V., Pervaiz, S., & Brenner, C. (2005) · PubMed · doi:10.14670/hh-20.205 · Cited by 359
Dichtl, W., Dulak, J., Frick, M., Alber, H. F., Schwarzacher, S. P., Ares, M. P. S., Nilsson, J., Pachinger, O., & Weidinger, F. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000043456.48735.20 · Cited by 344
Ortego, M., Bustos, C., Hernández-Presa, M. A., Tuñón, J., Dı́az, C., Hernández, G., & Egido, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00193-8 · Cited by 343
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
Gleissner, C. A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00001 · Cited by 339
Leptin Signaling and Obesity: Cardiovascular Consequences
Yang, R., & Barouch, L. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.156596 · Cited by 331
Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release
Samstad, E. O., Niyonzima, N., Nymo, S., Aune, M. H., Ryan, L., Bakke, S. S., Lappegård, K. T., Brekke, O.-L., Lambris, J. D., Damås, J. K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302484 · Cited by 289
Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., & Kaski, J. C. (2004) · Circulation · doi:10.1161/01.cir.0000142664.18739.92 · Cited by 274
Potential role of immune system activation-associated production of neopterin derivatives in humans
Hoffmann, G., Wirleitner, B., & Fuchs, D. (2003) · Inflammation Research · doi:10.1007/s00011-003-1181-9 · Cited by 244
Werner, E. R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G., Yim, J. J., Pfleiderer, W., & Wachter, H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39752-2 · Cited by 241
Impact of oxidized low density lipoprotein on vascular cells
Galle, J., Hansen-Hagge, T., Wanner, C., & Seibold, S. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.005 · Cited by 240
Katagiri, H., Yamada, T., & Oka, Y. (2007) · Circulation Research · doi:10.1161/circresaha.107.151621 · Cited by 235
Antioxidant supplements and mortality
Bjelakovic, G., Nikolova, D., & Gluud, C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000009 · Cited by 234
Tetrahydrobiopterin in Cardiovascular Health and Disease
Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M., & Crabtree, M. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5566 · Cited by 231
Neopterin production, tryptophan degradation, and mental depression—What is the link?
Widner, B., Laich, A., Sperner-Unterweger, B., Ledochowski, M., & Fuchs, D. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00006-5 · Cited by 231
Epigenetic Changes in Early Life and Future Risk of Obesity
Lillycrop, K. A., & Burdge, G. C. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.122 · Cited by 222
Huber, S. A., Sakkinen, P., David, C., Newell, M. K., & Tracy, R. P. (2001) · Circulation · doi:10.1161/01.cir.103.21.2610 · Cited by 211
Type 1 T helper and type 2 T helper cells: Functions, regulation and role in protection and disease
Romagnani, S. (1992) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02591635 · Cited by 209
Thomas, S. R., & Stocker, R. (1999) · Redox Report · doi:10.1179/135100099101534927 · Cited by 208
Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas
Shimizu, K., Shichiri, M., Libby, P., Lee, R. T., & Mitchell, R. N. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19855 · Cited by 200
Rossi, F., & Zatti, M. (1964) · Experientia · doi:10.1007/bf02146019 · Cited by 198
Concomitant presence of N-nitroso and S-nitroso proteins in human plasma
Rassaf, T., Bryan, N. S., Kelm, M., & Feelisch, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01183-8 · Cited by 192
Immune activation and degradation of tryptophan in coronary heart disease
Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Erglis, A., Trusinskis, K., & Fuchs, D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01186.x · Cited by 190
Cheung, M. C., Zhao, X.-Q., Chait, A., Albers, J. J., & Brown, B. G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.095151 · Cited by 190
Human macrophages degrade tryptophan upon induction by interferon-gamma
Werner, E. R., Bitterlich, G., Fuchs, D., Hausen, A., Reibnegger, G., Szabo, G., Dierich, M. P., & Wachter, H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90149-4 · Cited by 189
Cholesterol Crystals and Inflammation
Grebe, A., & Latz, E. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-012-0313-z · Cited by 188
Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis
Corti, R., Hutter, R., Badimón, J. J., & Fuster, V. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000036027.39353.70 · Cited by 187
Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis
Schulte, S., Sukhova, G. K., & Libby, P. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070776 · Cited by 187
Mangge, H., Summers, K. L., Meinitzer, A., Zelzer, S., Almer, G., Prassl, R., Schnedl, W. J., Reininghaus, E., Paulmichl, K., Weghuber, D., et al. (2014) · Obesity · doi:10.1002/oby.20491 · Cited by 186
Self-citationRedox regulation of the immune response
Gostner, J. M., Becker, K., Fuchs, D., & Sucher, R. (2013) · Redox Report · doi:10.1179/1351000213y.0000000044 · Cited by 185
Induction of Tryptophan Degradation In Vitro and In Vivo : A γ-Interferon-Stimulated Activity
BYRNE, G. I., LEHMANN, L. K., KIRSCHBAUM, J. G., BORDEN, E. C., LEE, C. M., & BROWN, R. R. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.389 · Cited by 183
The neglected significance of “antioxidative stress”
Poljsak, B., & Milisav, I. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/480895 · Cited by 177
Neopterin modulates toxicity mediated by reactive oxygen and chloride species
Weiss, G., Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Werner-Felmayer, G., Semenitz, E., Dierich, M. P., & Wachter, H. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80627-7 · Cited by 177
Macrophage biology and immunology: man is not a mouse
Schneemann, M., & Schoeden, G. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106702 · Cited by 176
Tetrahydrobiopterin Biosynthesis, Utilization and Pharmacological Effects
Werner-Felmayer, G., Golderer, G., & Werner, E. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605073 · Cited by 174
Hakamada-Taguchi, R., Uehara, Y., Kuribayashi, K., Numabe, A., Saito, K., Negoro, H., Fujita, T., Toyo-oka, T., & Kato, T. (2003) · Circulation Research · doi:10.1161/01.res.0000101298.76864.14 · Cited by 172
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy, D. J., & Yellon, D. M. (2008) · Heart · doi:10.1136/hrt.2007.125401 · Cited by 172
Vitamin E and Cardiovascular Disease
Saremi, A., & Arora, R. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31819cdc9a · Cited by 166
Neopterin, a prognostic marker in human malignancies
Sucher, R., Schroecksnadel, K., Weiss, G., Margreiter, R., Fuchs, D., & Brandacher, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.05.008 · Cited by 161
The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis
Fenyo, I. M., & Gafencu, A. V. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.005 · Cited by 157
Wolfs, I., Donners, M., & de Winther, M. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0320 · Cited by 157
Antioxidant effects of statins
Stoll, L. L., McCormick, M. L., Denning, G. M., & Weintraub, N. L. (2004) · Drugs of today · doi:10.1358/dot.2004.40.12.872573 · Cited by 156
Fraley, A. E., & Tsimikas, S. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245255.40634.b5 · Cited by 153
Pertovaara, M., Raitala, A., Juonala, M., Lehtimäki, T. J., Huhtala, H., Oja, S. S., Jokinen, E. V., Viikari, J. S. A., Raitakari, O. T., & Hurme, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03325.x · Cited by 150
Atherosclerosis and Cardiovascular Disease
Tsimikas, S., Tsironis, L. D., Tselepis, R. D., Thromb, A., July, V. B., In, L.-A. P. A., Tsimikas, S., Tsironis, L. D., & Tselepis, R. D. (1990) · Springer eBooks · doi:10.1007/978-94-009-0731-7 · Cited by 149
y, P. A., Arroyo‐Espliguero, R., Quiles, J., Roy, D., & Kaski, J. C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi111 · Cited by 146
Ray, K. K., Morrow, D. A., Sabatine, M. S., Shui, A. M., Rifai, N., Cannon, C. P., & Braunwald, E. (2007) · Circulation · doi:10.1161/circulationaha.106.666511 · Cited by 145
Immune activation and the anaemia associated with chronic inflammatory disorders
Fuchs, D., Hausen, A., Reibnegger, G. J., Werner, E. R., Werner‐Felmayer, G., Dierich, M. P., & WACHTER, H. (1991) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1991.tb00524.x · Cited by 142
Monocyte-derived dendritic cells release neopterin
Wirleitner, B., Reider, D., Ebner, S., Böck, G., Widner, B., Jaeger, M., Schennach, H., Romani, N., & Fuchs, D. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.6.1148 · Cited by 139
Elevated serum neopterin levels in atherosclerosis
Tatzber, F., Rabl, H., Koriska, K., Erhart, U., Puhl, H., Waeg, G., Krebs, A., & Esterbauer, H. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90061-7 · Cited by 138
Food, Nutrigenomics, and Neurodegeneration—Neuroprotection by What You Eat!
Virmani, A., Pinto, L., Binienda, Z., & Ali, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8498-3 · Cited by 137
Disturbed Tryptophan Metabolism in Cardiovascular Disease
Mangge, H., Stelzer, I., Reininghaus, E. Z., Weghuber, D., Postolache, T. T., & Fuchs, D. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140304105526 · Cited by 136
Self-citationT-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke
Engelbertsen, D., Andersson, L. I. M., Ljungcrantz, I., Wigren, M., Hedblad, B., Nilsson, J. Å., & Björkbacka, H. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300871 · Cited by 135
Increased concentrations of neopterin in carotid atherosclerosis
Weiß, G., Willeit, J., Kiechl, S. J., Fuchs, D., Jarosch, E., Oberhollenzer, F., Reibnegger, G. J., Tilz, M. G. P., Gerstenbrand, F., & WACHTER, H. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90131-7 · Cited by 134
Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular Disease
Schroecksnadel, K., Frick, B., Winkler, C., & Fuchs, D. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106777698379 · Cited by 134
Werner‐Felmayer, G., Werner, E. R., Fuchs, D., Hausen, A., Reibnegger, G. J., & WACHTER, H. (1989) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1989.370.2.1063 · Cited by 127
The Role of Neopterin in Atherogenesis and Cardiovascular Risk Assessment
Fuchs, D., y, P. A., Arroyo‐Espliguero, R., Jenny, M., Consuegra‐Sánchez, L., & Kaski, J. C. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789878247 · Cited by 125
Increased Neopterin in Patients With Chronic and Acute Coronary Syndromes
Schumacher, M., Halwachs, G., Tatzber, F., Fruhwald, F. M., Zweiker, R., Watzinger, N., Eber, B., Wilders-Truschnig, M. M., Esterbauer, H., & Klein, W. W. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00172-1 · Cited by 123
The regulation of tryptophan pyrrolase activity by tryptophan
Knox, W. E. (1966) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(66)90023-9 · Cited by 117
Post-translational Regulation of Human Indoleamine 2,3-Dioxygenase Activity by Nitric Oxide
Thomas, S. R., Terentis, A. C., Cai, H., Takikawa, O., Levina, A., Lay, P. A., Freewan, M., & Stocker, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700669200 · Cited by 111
[43] Antioxidant effects of nitric oxide
Wink, D. A., Yoram Vodovotz, B., Grisham, M. B., DeGraff, W., Cook, J. C., Pacelli, R., Krishna, M. C., & Mitchell, J. B. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)01105-2 · Cited by 110
S -Nitrosothiols and the S -Nitrosoproteome of the Cardiovascular System
Maron, B. A., Tang, S., & Loscalzo, J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4744 · Cited by 110
Niinisalo, P., Raitala, A., Pertovaara, M., Oja, S. S., Lehtimäki, T. J., Kähönen, M. A. P., Reunanen, A., Jula, A., Moilanen, L., Kesäniemi, Y. A., et al. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802245685 · Cited by 107
Oxidative Stress and Cardiovascular Disease: Antioxidants and Unresolved Issues
Sachidanandam, K., Fagan, S. C., & Ergul, A. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2005.tb00160.x · Cited by 105
Trans fatty acids and cardiovascular risk: A unique cardiometabolic imprint?
Mozaffarian, D., & Willett, W. C. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0065-9 · Cited by 104
Fuchs, D., Jaeger, M., Widner, B., Wirleitner, B., Artner‐Dworzak, E., & Leblhuber, F. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.113 · Cited by 103
Immune Activation and Decreased Tryptophan in Patients with HIV-1 Infection
Fuchs, D., FORSMAN, A., Hagberg, L., LARSSON, M., Norkrans, G., Reibnegger, G. J., Werner, E. R., & WACHTER, H. (1990) · Journal of Interferon Research · doi:10.1089/jir.1990.10.599 · Cited by 102
Alberati-Giani, D., Malherbe, P., Ricciardi‐Castagnoli, P., Köhler, C., Denis‐Donini, S., & Cesura, A. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.419 · Cited by 101
Maier, E., Kurz, K., Jenny, M., Schennach, H., Ueberall, F., & Fuchs, D. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.04.042 · Cited by 101
Natural antioxidant compounds in risk factors for CVD
Kaliora, A. C., & Dedoussis, G. V. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.04.018 · Cited by 99
Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection
Vardi, M., Levy, N. S., & Levy, A. P. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r026641 · Cited by 98
Murr, C., Winklhofer‐Roob, B. M., Schroecksnadel, K., Maritschnegg, M., Mangge, H., Böhm, B. O., Winkelmann, B. R., März, W., & Fuchs, D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.047 · Cited by 96
Self-citationAntioxidants and endothelium protection
Praticò, D. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.005 · Cited by 94
A systems biology approach to understanding atherosclerosis
Ramsey, S. A., Gold, E. S., & Aderem, A. A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000063 · Cited by 92
Is there a role for supplemented antioxidants in the prevention of atherosclerosis?
Katsiki, N., & Manes, C. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.10.011 · Cited by 91
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
&NA; (1993) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199311000-00009 · Cited by 91
Antitumoral Activity of Interferon-γ Involved in Impaired Immune Function in Cancer Patients
Brandacher, G., Winkler, C., Schroecksnadel, K., Margreiter, R., & Fuchs, D. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017768 · Cited by 89
Sucher, R., Fischler, K., Oberhuber, R., Kronberger, I. E., Margreiter, C., Öllinger, R., Schneeberger, S., Fuchs, D., Werner, E. R., Watschinger, K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002777 · Cited by 89
Graham, A., Hassall, D. G., Rafique, S., & Owen, J. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00162-7 · Cited by 88
Mechanism of Statin-Induced Rhabdomyolysis
Sakamoto, K., & Kimura, J. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r06cp · Cited by 88
Gerss, J., & Köpcke, W. (2009) · PubMed · Cited by 87
Tanaka, K., Nagata, D., Hirata, Y., Tabata, Y., Nagai, R., & Sata, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.016 · Cited by 87
Neurauter, G., Wirleitner, B., Laich, A., Schennach, H., WEISS, G., & Fuchs, D. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02021.x · Cited by 86
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J. (1993) · The Nurse Practitioner · doi:10.1097/00006205-199307000-00001 · Cited by 86
HDL‐paraoxonase and Membrane Lipid Peroxidation: A Comparison Between Healthy and Obese Subjects
Ferretti, G., Bacchetti, T., Masciangelo, S., & Bicchiega, V. (2009) · Obesity · doi:10.1038/oby.2009.338 · Cited by 81
Cf, N. (1986) · PubMed · Cited by 81
Wellenius, G. A., Mukamal, K. J., Kulshreshtha, A., Asonganyi, S., & Mittleman, M. A. (2008) · Circulation · doi:10.1161/circulationaha.107.741058 · Cited by 80
Jenny, M., Klieber, M., Zaknun, D., Schroecksnadel, S., Kurz, K., Ledochowski, M., Schennach, H., & Fuchs, D. (2010) · Inflammation Research · doi:10.1007/s00011-010-0244-y · Cited by 73
Zaknun, D., Schroecksnadel, S., Kurz, K., & Fuchs, D. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000329137 · Cited by 67
Antioxidant vitamin supplementation in cardiovascular diseases.
Riccioni, G., Bucciarelli, T., Mancini, B., Corradi, F., Ilio, C. D., Mattei, P. A., & D’Orazio, N. (2007) · PubMed · Cited by 67
Cytokine network and T cell immunity in atherosclerosis
Ait‐Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0143-x · Cited by 65
Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation
Stelzer, I., Zelzer, S., Raggam, R. B., Prüller, F., Truschnig-Wilders, M., Meinitzer, A., Schnedl, W. J., Horejsi, R., Möller, R., Weghuber, D., et al. (2011) · Translational research · doi:10.1016/j.trsl.2011.10.001 · Cited by 63
Self-citationChrysohoou, C. A., Panagiotakos, D. B., Pitsavos, C. S., Skoumas, J., Economou, M., Papadimitriou, L., & Stefanadis, C. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.030 · Cited by 62
Cangemi, R., Loffredo, L., Carnevale, R., Perri, L., Patrizi, M. P., Sanguigni, V., Pignatelli, P., & Violi, F. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm565 · Cited by 61
Schroecksnadel, K., Winkler, C., Wirleitner, B., Schennach, H., & Fuchs, D. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02746.x · Cited by 60
Debreceni, B., & Debreceni, L. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00266.x · Cited by 58
van Haelst, P. L., Liem, A. H., Boven, A. J. V., Veeger, N. J. G. M., van Veldhuisen, D. J., Tervaert, J. W. C., Gans, R. O. B., & Zijlstra, F. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.07.031 · Cited by 56
Adachi, T., Naruko, T., Itoh, A., Komatsu, R., Abe, Y., Shirai, N., Yamashita, H., Ehara, S., Nakagawa, M., Kitabayashi, C., et al. (2007) · Heart · doi:10.1136/hrt.2006.109736 · Cited by 56
Kaski, J., Consuegra-Sánchez, L., Fernández-Bergés, D., Cruz-Fernández, J. M., García-Moll, X., Marrugat, J., Mostaza, J., Toro-Cebada, R., González-Juanatey, J., & Guzmán-Martínez, G. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.01.009 · Cited by 53
Ciardi, C., Jenny, M., Tschoner, A., Ueberall, F., Patsch, J. R., Pedrini, M. T., Ebenbichler, C. F., & Fuchs, D. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003680 · Cited by 52
Ghazalpour, A., Doss, S., Yang, X., Aten, J. E., Toomey, E. M., van Nas, A., Wang, S. S.-M., Drake, T. A., & Lusis, A. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400006-jlr200 · Cited by 49
Antioxidant Food Supplements and Obesity-Related Inflammation
Mangge, H., Summers, K. L., Almer, G., Prassl, R., Weghuber, D., Schnedl, W. J., & Fuchs, D. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320180004 · Cited by 48
Self-citationNeopterin induces pro‐atherothrombotic phenotype in human coronary endothelial cells
Cirillo, P. L., Pacileo, M., Rosa, S. D., Calabrò, P., Gargiulo, A., Angri, V., GRANATO‐CORIGLIANO, F., Fiorentino, I., Prevete, N., Palma, R. D., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02125.x · Cited by 47
Possible role of cytokine‐induced tryptophan degradation in anaemia of inflammation
Weiss, G., Schroecksnadel, K., Mattle, V., Winkler, C., Konwalinka, G., & Fuchs, D. (2004) · European Journal Of Haematology · doi:10.1046/j.0902-4441.2003.00197.x · Cited by 47
T Helper Cell Polarization in Healthy People: Implications for Cardiovascular Disease
Olson, N. C., Sallam, R. M., Doyle, M. F., Tracy, R. P., & Huber, S. A. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9496-6 · Cited by 46
Gurfinkel, E., Scirica, B. M., Bozovich, G., Macchia, A., Manos, E. J., & Mautner, B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00905-9 · Cited by 46
Preadipocyte conversion to macrophage. Evidence of plasticity
Charrière, G. M., Cousin, B., Arnaud, E., André, M., Bacou, F., Pénicaud, L., & Casteilla, L. (2003) · HAL · Cited by 45
The Role of Vitamin D in Atherosclerosis Inflammation Revisited: More a Bystander than a Player?
Mangge, H., Weghuber, D., Prassl, R., Haara, A., Schnedl, W. J., Postolache, T. T., & Fuchs, D. (2015) · Current Vascular Pharmacology · doi:10.2174/1570161111666131209125454 · Cited by 42
Self-citationLillycrop, K. A., & Burdge, G. C. (2011) · Lifestyle Genomics · doi:10.1159/000334857 · Cited by 41
Should antioxidant status be considered in interventional trials with antioxidants?
Violi, F., Loffredo, L., Musella, L., & Marcoccia, A. (2004) · Heart · doi:10.1136/hrt.2003.026930 · Cited by 41
Magen, E., Borkow, G., Bentwich, Z., Mishal, J., & Scharf, S. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.09.028 · Cited by 40
Neopterin Derivatives Modulate the Nitration of Tyrosine by Peroxynitrite
Widner, B., Baier‐Bitterlich, G., Wede, I., Wirleitner, B., & Fuchs, D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8856 · Cited by 38
Zelzer, S., Fuchs, N., Almer, G., Raggam, R. B., Prüller, F., Truschnig-Wilders, M., Schnedl, W. J., Horejsi, R., Möller, R., Weghuber, D., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.031 · Cited by 38
Self-citationFang, F. C., & Nathan, C. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206715 · Cited by 37
Sivasankaran, S. (2010) · The Indian Journal of Medical Research · doi:10.4103/ijmr.2010_132_05_608 · Cited by 37
Vitamin C and E Suppress Mitogen-Stimulated Peripheral Blood Mononuclear Cells in vitro
Winkler, C., Schroecksnadel, K., Schennach, H., & Fuchs, D. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000096438 · Cited by 36
Walter, R. B., Fuchs, D., Weiß, G., Walter, T. R., & Reinhart, W. H. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.200 · Cited by 35
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2011.06.028 · Cited by 33
Immunoregulatory Impact of Food Antioxidants
Gostner, J. M., Ciardi, C., Becker, K., Fuchs, D., & Sucher, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990047 · Cited by 30
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Stockman, J. A. (2009) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)79001-8 · Cited by 28
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Howard, W. J. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79129-7 · Cited by 28
Claudio Napoli, A. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0156-x · Cited by 24
Schroecksnadel, K., Grammer, T. B., Boehm, B. O., März, W., & Fuchs, D. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0422 · Cited by 24
Homocysteine but not neopterin declines in demented patients on B vitamins
Frick, B., Gruber, B., Schroecksnadel, K., Leblhuber, F., & Fuchs, D. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0539-x · Cited by 23
Cardiac Function, Inflammatory Mediators and Mortality in Critical Limb Ischemia
Barani, J., Mattiasson, I., Lindblad, B., & Gottsäter, A. (2006) · Angiology · doi:10.1177/0003319706290743 · Cited by 22
Nitric Oxide Synthase and Antimicrobial Armature of Human Macrophages
Fuchs, D., Murr, C., Reibnegger, G. J., Weiss, G., Werner, E. R., Werner‐Felmayer, G., & WACHTER, H. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.1.224 · Cited by 20
Gaston, B. M., & Stamler, J. S. (2002) · Springer eBooks · doi:10.1007/0-306-46816-6_3 · Cited by 16
Rhodes, T., Norquist, J. M., Sisk, C. M., McQuarrie, K., Trovato, A., Liao, J., Miller, T., Maccubbin, D., & Watson, D. J. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12213 · Cited by 13
High-density lipoprotein cholesterol targeting for novel drug discovery: where have we gone wrong?
Escolá‐Gil, J. C., Cedó, L., & Blanco‐Vaca, F. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.871257 · Cited by 10
Schroecksnadel, K., Walter, R. B., Weiss, G., Mark, M., Reinhart, W. H., & Fuchs, D. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.121 · Cited by 8
Should we treat all patients with coronary heart disease or the equivalent with statins?
Baginsky, P. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0005-y · Cited by 2
Cited by
Role of homocysteine in the development of cardiovascular disease
Ganguly, P., & Alam, S. F. (2015) · Nutrition Journal · doi:10.1186/1475-2891-14-6 · Cited by 1,028
Thyroid Hormones, Oxidative Stress, and Inflammation
Mancini, A., Di Segni, C., Raimondo, S., Olivieri, G., Silvestrini, A., Meucci, E., & Currò, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6757154 · Cited by 529
The mechanisms of air pollution and particulate matter in cardiovascular diseases
Fiordelisi, A., Piscitelli, P., Trimarco, B., Coscioni, E., Iaccarino, G., & Sorriento, D. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9606-7 · Cited by 485
The role of Nrf2 in oxidative stress-induced endothelial injuries
Chen, B., Lu, Y., Chen, Y., & Cheng, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0662 · Cited by 400
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Spahis, S., Delvin, E., Borys, J.-M., & Levy, E. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6776 · Cited by 386
Metadata
- Authors
- Mangge, H.
- Venue
- World Journal of Cardiology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 6
- Issue
- 6
- Pages
- 462
- ISSN
- 1949-8462 (ISSN-L)
- OpenAlex
- W1979711098
- Cited by
- 338
- References
- 184
- FWCI
- 22.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.